Fig. 7From: PIWIL4 and SUPT5H combine to predict prognosis and immune landscape in intrahepatic cholangiocarcinomaA Correlation analysis of signature with tumor-infiltrating immune cells. B–D The IC50 for frequently-used chemotherapeutics drugs, (B) Docetaxel, (C) Gefitinib, (D) GemcitabineBack to article page